BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22401303)

  • 1. Magnetic resonance spectroscopy of cancer metabolism and response to therapy.
    McIntyre DJ; Madhu B; Lee SH; Griffiths JR
    Radiat Res; 2012 Apr; 177(4):398-435. PubMed ID: 22401303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.
    Li Y; Park I; Nelson SJ
    Cancer J; 2015; 21(2):123-8. PubMed ID: 25815853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiles of cancer cells.
    Griffin JL; Shockcor JP
    Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
    [No Abstract]   [Full Text] [Related]  

  • 4. CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response.
    Chan KW; Jiang L; Cheng M; Wijnen JP; Liu G; Huang P; van Zijl PC; McMahon MT; Glunde K
    NMR Biomed; 2016 Jun; 29(6):806-16. PubMed ID: 27100284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the tumor microenvironment in radiotherapy: perfusion, hypoxia, and metabolism.
    Matsuo M; Matsumoto S; Mitchell JB; Krishna MC; Camphausen K
    Semin Radiat Oncol; 2014 Jul; 24(3):210-7. PubMed ID: 24931096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron paramagnetic resonance imaging of tumor pO₂.
    Krishna MC; Matsumoto S; Yasui H; Saito K; Devasahayam N; Subramanian S; Mitchell JB
    Radiat Res; 2012 Apr; 177(4):376-86. PubMed ID: 22332927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology].
    Semmler W; Gückel F; Bachert-Baumann P; Lorenz WJ; van Kaick G
    Radiologe; 1989 Jul; 29(7):330-5. PubMed ID: 2667032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic tumor imaging using magnetic resonance spectroscopy.
    Glunde K; Bhujwalla ZM
    Semin Oncol; 2011 Feb; 38(1):26-41. PubMed ID: 21362514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of cancer: MR spectroscopy and beyond.
    Pinker K; Stadlbauer A; Bogner W; Gruber S; Helbich TH
    Eur J Radiol; 2012 Mar; 81(3):566-77. PubMed ID: 20554145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.
    Glunde K; Artemov D; Penet MF; Jacobs MA; Bhujwalla ZM
    Chem Rev; 2010 May; 110(5):3043-59. PubMed ID: 20384323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer: when recycling becomes a weakness].
    Sonveaux P; Végran F; Verrax J; De Saedeleer CJ; Diepart C; Jordan BF; Gallez B; Feron O
    Med Sci (Paris); 2009 Apr; 25(4):327-9. PubMed ID: 19409177
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.
    Beloueche-Babari M; Chung YL; Al-Saffar NM; Falck-Miniotis M; Leach MO
    Br J Cancer; 2010 Jan; 102(1):1-7. PubMed ID: 19935796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
    Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
    Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue metabolism studied in vivo by nuclear magnetic resonance.
    Williams SR; Gadian DG
    Q J Exp Physiol; 1986 Jul; 71(3):335-60. PubMed ID: 3532161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using metabolomics to monitor anticancer drugs.
    Chung YL; Griffiths JR
    Ernst Schering Found Symp Proc; 2007; (4):55-78. PubMed ID: 18811053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy applied to clinical oncology.
    Leach MO
    Technol Health Care; 1994 Dec; 2(4):235-46. PubMed ID: 7842308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer.
    Yankeelov TE; Arlinghaus LR; Li X; Gore JC
    Semin Oncol; 2011 Feb; 38(1):16-25. PubMed ID: 21362513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy.
    Griffiths JR; Glickson JD
    Adv Drug Deliv Rev; 2000 Mar; 41(1):75-89. PubMed ID: 10699306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology.
    Zakian KL; Koutcher JA; Ballon D; Hricak H; Ling CC
    Semin Radiat Oncol; 2001 Jan; 11(1):3-15. PubMed ID: 11146038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo monitoring of fluoropyrimidine metabolites: magnetic resonance spectroscopy in the evaluation of 5-fluorouracil.
    Findlay MP; Leach MO
    Anticancer Drugs; 1994 Jun; 5(3):260-80. PubMed ID: 7919450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.